Legend Biotech (LEGN) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Legend Biotech is undergoing a significant financial restructuring as Genscript Biotech has decided to deconsolidate the company’s financial statements. This move follows Genscript’s loss of control over voting power at Legend Biotech’s 2024 Annual General Meeting. Investors in the biotech sector may find this development noteworthy as it could impact the company’s financial reporting and market perception.
For further insights into LEGN stock, check out TipRanks’ Stock Analysis page.
